GlassScriptPhysician profile
Sergio Alberto Murillo Herrera
NPI 1598923757
$7,431.26
in general payments reported to CMS, 2019-2025
52 companies · $1,434 in 2025
The $1,434 reported for 2025 was more than what 91% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $512 · 2020: $660 · 2021: $1,044 · 2022: $1,372 · 2023: $1,413 · 2024: $997 · 2025: $1,434.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,843.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,842.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,738.41 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $1,019.29 | 2019-2025 | Farxiga, Breztri, Airsupra |
| Pfizer INC. | $558.09 | 2019-2025 | |
| Novo Nordisk INC | $530.03 | 2019-2025 | Ozempic, Wegovy, Rybelsus |
| Janssen Pharmaceuticals, INC | $464.99 | 2019-2024 | Xarelto |
| Amgen INC. | $338.07 | 2019-2025 | Otezla, Repatha, Otezla |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $210.28 | 2022-2025 | Caplyta |
| Exact Sciences Corporation | $204.67 | 2023-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Astellas Pharma US INC | $196.44 | 2020-2025 | Veozah, Myrbetriq |
| Bayer Healthcare Pharmaceuticals INC. | $196.33 | 2022-2025 | |
| Lilly USA, LLC | $172.83 | 2021-2024 | Mounjaro, Trulicity |
| Glaxosmithkline, LLC. | $160.38 | 2021 | |
| Novartis Pharmaceuticals Corporation | $117.11 | 2022-2025 | |
| Idorsia Pharmaceuticals US INC | $102.17 | 2022-2023 | Quviviq |
| Grifols USA, LLC | $93.39 | 2019-2021 |
Show all 52 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sergio Murillo Herrera listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.